Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Tissue Inhibitor of Metalloprotease-2: bioprocess development, physicochemical, biochemical and biological characterization of highly expressed recombinant protein

Published

Author(s)

Ananda Chowdhury, Robert G. Brinson, Beiyang Wei, William G. Stetler-Stevenson

Abstract

Tissue Inhibitor of Metalloprotease -2 (TIMP-2) is a secreted, 21 kDa, multifunctional protein. It was first described as an endogenous inhibitor of matrix metalloproteases (MMPs) that prevents protease-mediated breakdown of the extracellular matrix often observed in chronic diseases. TIMP-2, independent of its MMP inhibitory activity, also diminished growth factor- mediated cell proliferation in vitro, as well as neoangiogenesis and tumor growth in vivo. TIMP-2 is an excellent candidate for further pre-clinical development as a biologic therapy for cancer. Here we present a straightforward bioprocessing methodology that yields >35 mg/L TIMP- 2-6XHis-tagged protein from suspension HEK 293F cells. These enhanced TIMP-2-6XHis yields were achieved by optimization of both TIMP-2 cDNA codon sequence and cell culture conditions. Using a two-step chromatographic process, we achieved > 95 % purity with minimal processing losses. Purified TIMP-2-6XHis was free of mouse antigen and endotoxin contamination. Using Circular Dichroism and 2D nuclear magnetic resonance spectroscopies, TIMP-2-6XHis was determined to be monodisperse, properly folded, and refractory to pH changes, all important critical quality attributes for therapeutic development. Purified TIMP-2-6XHis inhibited MMP-2 enzymatic activity in a dose dependent fashion with an IC50 of 1.4 nmol / L. TIMP-2-6XHis pre-treatment of A549 lung cancer and JygM(A) triple-negative breast cancer cells in low nanomolar amounts inhibited the EGF-induced proliferation of these cells to basal (unstimulated) levels. The present study therefore not only offers a robust bioprocess methodology for TIMP-2 production but also characterizes critical physicochemical and biological attributes useful for monitoring quality control of the production process
Citation
Biochemistry
Volume
56
Issue
49

Keywords

TIMP-2, ECM, MMP, MMP-2, anti-proliferative, bio-therapeutic

Citation

Chowdhury, A. , Brinson, R. , Wei, B. and Stetler-Stevenson, W. (2017), Tissue Inhibitor of Metalloprotease-2: bioprocess development, physicochemical, biochemical and biological characterization of highly expressed recombinant protein, Biochemistry, [online], https://doi.org/10.1021/acs.biochem.7b00700 (Accessed June 13, 2024)

Issues

If you have any questions about this publication or are having problems accessing it, please contact reflib@nist.gov.

Created November 30, 2017, Updated October 12, 2021